| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |